DS
Dennis Suskind
Director

Dennis Suskind insider trades: Cme Group (CME) stock sales

Director, Cme Group Last trade Apr 29, 2025 62 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2016
6
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Dennis reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 29, 2025CME↓ Sell$271K
Nov 6, 2023CME↓ Sell$320K
Mar 10, 2021NAV↓ Sell$210K
Feb 12, 2021CME↓ Sell$183K
Jan 19, 2021NAV↓ Sell$110K
Dec 23, 2020NAV↓ Sell$88K
Aug 25, 2020CME↓ Sell$349K
Aug 9, 2019CME↓ Sell$319K
Sep 11, 2017CME↓ Sell$97K
Apr 28, 2017CME↓ Sell$127K
Feb 3, 2017CME↓ Sell$121K
Dec 9, 2016CME↓ Sell$122K
Nov 2, 2016CME↓ Sell$201K
Sep 1, 2016CME↓ Sell$109K
Jul 29, 2016CME↓ Sell$103K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CME insiders

Open-market trades in the last 12 months

About Dennis Suskind's insider trades

Dennis Suskind is a director at Cme Group (CME). Since Jul 29, 2016, Dennis has reported no open-market purchases and 15 sales worth $2.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (44 filings), shares returned to the company (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CME insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.